FormWeb • traZODone

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

traZODone

traZODone

Formulary Anti-Depressant Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Oleptro	TABLET, EXTENDED RELEASE, ORAL	150 mg, 300 mg
Desyrel	TABLET, ORAL	50 mg, 100 mg, 150 mg

VIEW MORE Selective-serotonin Reuptake Inhibitors, Serotonin Modulators

Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

traZODone (Oleptro)

150 mg extended release tablet daily
ONE 150 mg extended release tablet PLUS HALF 150 mg extended release tablet daily (Total: 175 mg)
300 mg extended release tablet daily
ONE 300 mg extended release tablet PLUS one 150 mg extended release PLUS HALF 150 mg extended release tablet (Total: 375 mg)

traZODone (Desyrel)

50 mg tablet q 8 hours
50 mg tablet q 6 hours
100 mg tablet q 8 hours
100 mg tablet q 6 hours

Desyrel medication guide

Oleptro medication guide

traZODone medication guide

Reviewed: September 28, 2010 (OLEPTRO)

Last updated: Aug. 21, 2017

Black Box Warning: Suicidal ideation

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.